Cargando…

Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progression

Activation of the tyrosine kinase c-Src promotes breast cancer progression and poor outcomes, yet the underlying mechanisms are incompletely understood. Here, we have shown that deletion of c-Src in a genetically engineered model mimicking the luminal B molecular subtype of breast cancer abrogated t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nandi, Ipshita, Smith, Harvey W., Sanguin-Gendreau, Virginie, Ji, Linjia, Pacis, Alain, Papavasiliou, Vasilios, Zuo, Dongmei, Nam, Stella, Attalla, Sherif S., Kim, Sung Hoon, Lusson, Sierra, Kuasne, Hellen, Fortier, Anne-Marie, Savage, Paul, Martinez Ramirez, Constanza, Park, Morag, Katzenellenbogen, John A., Katzenellenbogen, Benita S., Muller, William J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065076/ https://www.ncbi.nlm.nih.gov/pubmed/36795481 http://dx.doi.org/10.1172/JCI162324

Ejemplares similares

Targeting the oncogenic transcription factor FOXM1 to improve outcomes in all subtypes of breast cancer
por: Katzenellenbogen, Benita S., et al.
Publicado: (2023)

Transcription Regulation and Genome Rewiring Governing Sensitivity and Resistance to FOXM1 Inhibition in Breast Cancer
por: Ziegler, Yvonne, et al.
Publicado: (2021)

Suppression of Tumor Growth, Metastasis, and Signaling Pathways by Reducing FOXM1 Activity in Triple Negative Breast Cancer
por: Dey, Parama, et al.
Publicado: (2020)

Reversal of endocrine resistance in breast cancer: interrelationships among 14-3-3ζ, FOXM1, and a gene signature associated with mitosis
por: Bergamaschi, Anna, et al.
Publicado: (2011)

FOXM1 regulates glycolysis and energy production in multiple myeloma
por: Cheng, Yan, et al.
Publicado: (2022)

Estrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta - regulation by selective estrogen receptor modulators and importance in breast cancer
por: S Katzenellenbogen, Benita, et al.
Publicado: (2000)

An ErbB2/c-Src axis links bioenergetics with PRC2 translation to drive epigenetic reprogramming and mammary tumorigenesis
por: Smith, Harvey W., et al.
Publicado: (2019)

The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells
por: Bergamaschi, Anna, et al.
Publicado: (2014)

Suppression of FOXM1 activities and breast cancer growth in vitro and in vivo by a new class of compounds
por: Ziegler, Yvonne, et al.
Publicado: (2019)

Tamoxifen down-regulation of miR-451 increases 14-3-3ζ and promotes breast cancer cell survival and endocrine resistance
por: Bergamaschi, Anna, et al.
Publicado: (2011)

Emergence of β1 integrin-deficient breast tumours from dormancy involves both inactivation of p53 and generation of a permissive tumour microenvironment
por: Bui, Tung, et al.
Publicado: (2021)

Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators
por: Madak-Erdogan, Zeynep, et al.
Publicado: (2013)

Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators
por: Madak‐Erdogan, Zeynep, et al.
Publicado: (2017)

Macrophage-Elicited Loss of Estrogen Receptor Alpha in Breast Cancer Cells via Involvement of MAPK and c-Jun at the ESR1 Genomic Locus
por: Stossi, Fabio, et al.
Publicado: (2011)

Highly Sensitive Quantitative Imaging for Monitoring Single Cancer Cell Growth Kinetics and Drug Response
por: Mir, Mustafa, et al.
Publicado: (2014)

Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo
por: Lahlou, Hicham, et al.
Publicado: (2012)

Integration of Molecular Profiling and Chemical Imaging to Elucidate Fibroblast-Microenvironment Impact on Cancer Cell Phenotype and Endocrine Resistance in Breast Cancer
por: Holton, Sarah E., et al.
Publicado: (2014)

Transcriptomic analysis identifies gene networks regulated by estrogen receptor α (ERα) and ERβ that control distinct effects of different botanical estrogens
por: Gong, Ping, et al.
Publicado: (2014)

Pathway Preferential Estrogens Prevent Hepatosteatosis Due to Ovariectomy and High-Fat Diets
por: Zuo, Qianying, et al.
Publicado: (2021)

OR11-01 A New Model for Estrogen Receptor-alpha Antagonist Mechanism of Action
por: Nwachukwu, Jerome C, et al.
Publicado: (2023)

Telomerase Induction in HPV Infection and Oncogenesis
por: Katzenellenbogen, Rachel
Publicado: (2017)

Defining the Energetic Basis for a Conformational Switch Mediating Ligand-Independent Activation of Mutant Estrogen Receptors in Breast Cancer
por: Mayne, Christopher G., et al.
Publicado: (2021)

Respective role of membrane and nuclear estrogen receptor (ER) α in the mandible of growing mice: Implications for ERα modulation
por: Vinel, Alexia, et al.
Publicado: (2018)

The structural pervasiveness of estrogenic activity.
por: Katzenellenbogen, J A
Publicado: (1995)

PET Imaging Agents (FES, FFNP, and FDHT) for Estrogen, Androgen, and Progesterone Receptors to Improve Management of Breast and Prostate Cancers by Functional Imaging
por: Katzenellenbogen, John A.
Publicado: (2020)

Stringing along the estrogen receptor to engage with DNA
por: Katzenellenbogen, John A.
Publicado: (2023)

Highly Selective Salicylketoxime-Based Estrogen Receptor β Agonists Display Antiproliferative Activities in a Glioma Model
por: Paterni, Ilaria, et al.
Publicado: (2015)

OR09-2 Pathway Preferential Estrogens Prevent Hepatosteatosis Due to Ovariectomy and High-Fat Diets
por: Zuo, Qianying, et al.
Publicado: (2019)

Chemogenomic profiling of breast cancer patient-derived xenografts reveals targetable vulnerabilities for difficult-to-treat tumors
por: Savage, Paul, et al.
Publicado: (2020)

Designer antiandrogens join the race against drug resistance
por: Josan, Jatinder S, et al.
Publicado: (2013)

NFX1, Its Isoforms and Roles in Biology, Disease and Cancer
por: Chintala, Sreenivasulu, et al.
Publicado: (2021)

OR12-07 Full Antagonism of Breast Cancer Cell Proliferation Can Result from Many Ligand-Induced Conformational Distortions of the Estrogen Receptor Ligand Binding Domain
por: Nwachukwu, Jerome, et al.
Publicado: (2020)

Adherence to Secondary Prophylaxis Among Patients with Acute  Rheumatic Fever and Rheumatic Heart Disease
por: Woods, John A., et al.
Publicado: (2019)

Predicting Diabetic Nephropathy Using a Multifactorial Genetic Model
por: Blech, Ilana, et al.
Publicado: (2011)

FOXM1: Functional Roles of FOXM1 in Non-Malignant Diseases
por: Zhang, Zhenwang, et al.
Publicado: (2023)

The Activation Function-1 of Estrogen Receptor Alpha Prevents Arterial Neointima Development Through a Direct Effect on Smooth Muscle Cells
por: Smirnova, Natalia F., et al.
Publicado: (2015)

Australia's National Bowel Cancer Screening Program: does it work for Indigenous Australians?
por: Christou, Aliki, et al.
Publicado: (2010)

Post-Transcriptional Gene Regulation by HPV 16E6 and Its Host Protein Partners
por: Billingsley, Caylin L., et al.
Publicado: (2022)

Estrogen receptor alpha somatic mutations Y537S and D538G confer breast cancer endocrine resistance by stabilizing the activating function-2 binding conformation
por: Fanning, Sean W, et al.
Publicado: (2016)

π–π Interaction Energies as Determinants of the Photodimerization of Mono-, Di-, and Triazastilbenes
por: Parent, Alexander A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2cnvg5q0a69p4v17jof9hr51jq